Print Page | Contact Us | Sign In | Join ASFA
2020 Webinar Schedule

 2020 Webinars Schedule

American Society for Apheresis (ASFA) is pleased to announce that participation in the 2020 webinar series is FREE for all ASFA members! There is a $75 registration fee per webinar for non-members.

If you are interested in leading a future ASFA topical webinar or nursing case study webinar, please reach out to ASFA Head Office.

New: Please note that you also need to register with GoToWebinar in order to receive IP specific login details!

  

 

January 

 

Title: Blood Primes and the Pediatric Patient
Date: Wednesday, January 15, 2020 
Time: 12:00pm - 1:00pm ET
Speaker: Mary Sanders BSN, RN CPN 

Learning Objectives: 

  1. Review when blood primes are indicated, and the unique challenges presented in the pediatric patient.
  2. Two case studies - Custom Primes for TPE and ECP with a Modified Blood Prime 

 Registration has closed

Members can watch 
the recording in 
ASFA Access

February

 

Title: Blood Donations Screening for Babesia: Past and Future
Date: Wednesday, February 12, 2020 
Time: 12:00pm - 1:00pm ET
Speaker: Laura Tonnetti, MS, PhD

Learning Objectives: 

  1. Provide a background on transfusion-transmitted babesiosis.
  2. Describe babesia screening performed under investigational protocols.
  3. Discuss the requirements and challenges of implementing babesia screening as recommended in the May 2019 FDA guidance.

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

March

 

Title: LDL Apheresis as a Treatment of FSGS
Date: Wednesday, March 25, 2020 
Time: 12:00pm - 1:00pm ET
Speaker: Joshua J. Zaritsky MD, PhD 

Learning Objectives:

  1. Describe our current understanding of the diagnosis and treatment of pediatric FSGS
  2. Review the current data and protocols using liposorber to treat primary FSGS
  3. Review the current data and protocols using liposorber to treat recurrent FSGS

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

April 3

 

Title: COVID-19 and Convalescent Plasma Collection
Date: Friday, April 3, 2020
Time: 12:00pm - 2:00pm ET
Speakers: Drs. Louis Katz, Peter Marks, Beth Shaz, Evan Bloch, Zhong Liu

ASFA will host a webinar to help members understand the requirements and processes to collect and transfuse COVID-19 Convalescent Plasma:

  1. Background on COVID-19 - Dr. Louis M. Katz
  2. FDA Response - Dr. Peter Marks
  3. Blood Collection Perspective - Dr. Beth Shaz
  4. Hospital Perspective - Dr. Evan Bloch
  5. Chinese Experiences - Dr. Zhong Liu
  6. Q&A

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

April 22

 

Title: Apheresis in the Era of COVID-19: Staff Protection and Other Considerations
Date: Wednesday, April 22, 2020
Time: 12:00pm - 1:00pm ET
Speaker: Mehraboon Irani, MD

Learning Objectives:

  1. SARS CoV-2 the viral agent that causes COVID-19, including clinical and laboratory features of the disease
  2. Precautions to take including personal protective equipment (PPE) when performing apheresis on patients that do not have COVID-19
  3. Precautions to take when performing apheresis on patient with COVID-19

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

May 13

 

Title: Telapheresis in the Era of COVID-19 - Beginning of a Journey
Date: Wednesday, May 13, 2020
Time: 12:00pm - 1:00pm ET
Speakers: Walter Linz, MD, MBA, Jan Hofmann MD, MPH, MSc

Learning Objectives:

  1. Describe the basic elements of telemedicine in apheresis (telapheresis) and compare the three delivery models of therapeutic apheresis.
  2. Delineate the advantages of the telapheresis practice model in the age of COVID-19.
  3. Employ reimbursement strategies for telapheresis consultation and remote TA procedure supervision. 

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

May 27

 

Title: Centrifuge Based Therapeutic Plasma Exchange for Sepsis / Multiorgan Failure in COVID-19 Infection
Date: Wednesday, May 27, 2020
Time: 12:00pm - 1:30pm ET (1.5 Hour Duration)
Speakers: Dr.Joseph Restivo, Dr. L. Keith Scott, Dr. Philip Keith, Claire Caton & Shannon Scott

Learning Objectives:

  1. Discuss pertinent clinical features seen in severe/ life-threatening COVID-19 infection.
  2. Discuss a rationale for use of therapeutic plasma exchange for the sepsis / multiorgan failure indication in these patients.
  3. Summarize early practical experiences and outcomes using TPE in patients with sepsis / multiorgan failure and COVID-19.

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

June 3

 

This webinar is hosted and supported by Terumo BCT. The information included has not been reviewed or endorsed by ASFA, and cannot substitute for the advice or direction of a health care professional, and the association makes no guarantees, nor can it assume any legal liability for the accuracy, completeness, or usefulness of such information or for any damage incurred directly or indirectly from the information. Reference to any specific product does not imply its endorsement, recommendation or preference by the American Society for Apheresis.  CEU/CMLE will not be offered for this program.

Title: Selective Removal of Inflammatory Cytokines with the Spectra Optia® Apheresis System and Marker D2000 Adsorption Cartridge
Date: Wednesday, June 3, 2020
Time: 1:00pm - 1:45pm ET (45 Minute Duration)
Speakers: Dawn Faller, RN, HP, Randy Wenthold & Donald J. Hillebrand

The FDA has issued an Emergency Use Authorization (EUA) for the use of Terumo BCT's Spectra Optia Apheresis System and Marker Therapeutics AG's D2000 Adsorption Cartridge for this purpose. What to expect from this webinar:
  • Gain insight into the Terumo BCT and Marker Therapeutics AG EUA 
  • Learn more about the Spectra Optia Apheresis System's SPD protocol
  • Understand how the Marker D2000 Adsorption Cartridge works
  • Discover the wide range of inflammatory conditions where this combination is potentially applicable

Hosted by:

Registration has closed

 

June 12

 
 

Title: Updates on the Use of COVID-19 Convalescent Plasma
Date: Friday, June 12, 2020
Time: 12:00pm - 2:00pm ET (2 Hour Duration)
Speakers: Peter Marks, MD, PhD, Nicole M. Bouvier, MD, Evan Bloch, MD, MS & Dr. Zhong Liu

Learning Objectives:

  1. Updates from the FDA: Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration
  2. Reports on the US study:
    a. Nicole M. Bouvier, MD, Associate Professor, Department of Medicine, Division of Infectious Diseases Department of Microbiology Icahn School of Medicine at Mount Sinai
    b. Evan M. Bloch, MD, MS, Associate Professor of Pathology, Johns Hopkins University School of Medicine
  3. Reports on the Chinese study: Dr. Zhong Liu, Vice President, Institute of Blood Transfusion, Chinese Academy of Medical Science
  4. Q & A

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

June 19

 

Title: Sickle Cell Disease: Tips for Improving Outcomes
Date: Friday, June 19, 2020: World Sickle Cell Day
Time: 12:00pm - 1:00pm ET
Speakers: Julie Kanter, MD and Marisa Marques, MD 

Learning Objectives:

  1. Recognize the systemic complications in sickle cell disease (JK)
  2. Identify the transfusion related complications in sickle cell disease (MM)
  3. Discuss how depletion exchange can be used for patients on chronic transfusion therapy (MM)
  4. Identify novel therapies in development for sickle cell disease (JK)

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

August

 

This webinar is hosted and supported by Fresenius Kabi. The information included has not been reviewed or endorsed by ASFA, and cannot substitute for the advice or direction of a health care professional, and the association makes no guarantees, nor can it assume any legal liability for the accuracy, completeness, or usefulness of such information or for any damage incurred directly or indirectly from the information. Reference to any specific product does not imply its endorsement, recommendation or preference by the American Society for Apheresis.   CEU/CMLE will not be offered for this program.

Title: Essentials in Apheresis Therapies: Platelet Collections and Therapeutics Apheresis
Date: Wednesday, August 5, 2020
Time: 12:00pm - 1:00pm ET
Speakers: Dr. Joanne Becker, MD, Lorna Domingo, BSN, RN, MAN, Linda Meulners, RN, and Selina Gosset, BSN, RN

Learning Objectives:
  1. Discuss staffing and training in donor and therapeutics scenarios
  2. Discuss experience with pediatrics MNC and Blood Prime – review Pediatric Case Study
  3. Understand Patient indications and programming parameters for Red Blood Cell depletion

Hosted By:

Watch this free webinar recording here
 

September

 

Title: Sickle Cell Disease Treatment in Apheresis
Date: Wednesday, September 9, 2020
Time: 12:00pm - 1:00pm ET
Speaker: Timothy J. Roberts, BSN, RN, QIA

Learning Objectives:

  1. Attendees will be able to state the population that would benefit from this Red Blood Cell Exchange
  2. Attendees will be able to state reasons to do Red Blood Cell Exchange rather than simple red cell transfusions
  3. Attendees will be able to list possible complications from Red Blood Cell Exchange

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

October

 

Title: CAR-T Cell Therapy for Multiple Myeloma: What Have We Learned?
Date: Wednesday, October 7, 2020
Time: 12:00pm - 1:00pm ET
Speaker: Adam D. Cohen, MD

Dr. Cohen received his medical degree and Internal medicine training from the University of Pennsylvania and completed his Hematology/Medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. Board certified in internal medicine, medical oncology, and hematology, Dr. Cohen is a member of ASH, ASCO, AACR and the International Myeloma Society, and a reviewer for a number of peer-reviewed journals. He has written dozens of original articles, book chapters, and reviews on cancer immunotherapy, multiple myeloma, amyloidosis, and stem cell transplant.

Dr. Cohen is currently Director of Myeloma Immunotherapy and an Assistant Professor in the Hematology/Oncology Division at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia.

Learning Objectives: 

  1. Describe rationale for CAR T cell therapy for myeloma and current targets;
  2. Identify CAR T cell products currently in development for myeloma;
  3. Understand clinical activity and toxicities of CAR T cell therapy for myeloma

©2020 American Society for Apheresis (ASFA). All rights reserved.
American Society for Apheresis and the ASFA logo are registered service marks.